LONG-ACTING INJECTABLE CABOTEGRAVIR FOR PREP

Clinical trials for LONG-ACTING INJECTABLE CABOTEGRAVIR FOR PREP explained in plain language.

Never miss a new study

Get alerted when new LONG-ACTING INJECTABLE CABOTEGRAVIR FOR PREP trials appear

Sign up with your email to follow new studies for LONG-ACTING INJECTABLE CABOTEGRAVIR FOR PREP, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Malawi trial aims to keep High-Risk groups on HIV prevention drugs

Prevention Recruiting now

This study is testing a package of support strategies to help people at high risk for HIV in Malawi continue taking their prevention medications. It will compare standard care to enhanced support at clinics and community centers, focusing on helping people stick with both daily p…

Matched conditions: LONG-ACTING INJECTABLE CABOTEGRAVIR FOR PREP

Phase: NA • Sponsor: Georgetown University • Aim: Prevention

Last updated Mar 27, 2026 12:38 UTC

LONG-ACTING INJECTABLE CABOTEGRAVIR FOR PREP

Get alerted when new LONG-ACTING INJECTABLE CABOTEGRAVIR FOR PREP trials appear

Malawi trial aims to keep High-Risk groups on HIV prevention drugs